Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TIP in CF Patients with Burkholderia Cepacia Complex
NCT02212587Phase 1Completed
- Sponsor
- Unity Health Toronto
- Start
- Sep 2014
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of tobramycin in Burkholderia cepacia complex infection (Bcc), sponsored by Unity Health Toronto. Primary endpoint: Change in Sputum Density of Burkholderia Cepacia Complex at Day 28. Started Sep 2014; status: completed.
02
Drugs
tobramycin
03
Conditions
Burkholderia cepacia complex infection (Bcc)
Beyond the preview
Go deeper on NCT02212587.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02212587.